Infant cholestasis is conjugated hyperbilirubinemia (often with dark urine and acholic stools) and demands a differential that includes common genetic/metabolic liver disease such as alpha-1 antitrypsin deficiency.
You are evaluating a 72-day-old male infant for failure to thrive. His parents tell you that the child has always been a fussy, poor eater and that he has never gained weight well. The parents also tell you that recently they have noted very dark urine in this child's diaper, whereas his stools are becoming lighter and lighter in color.
On examination, you note a mildly fussy, thin child with visible jaundice, hepatomegaly, and splenomegaly. Laboratory studies reveal an elevated total bilirubin level with the direct fraction of bilirubin measured at more than 20% of the total. Aspartate and alanine transaminase values are elevated to more than 2 times their normal value.
Upon questioning, the parents admit that this pattern of disease is prevalent in their family, and several cousins have progressed through similar problems during their first year of life. Those cousins are now school age and are reportedly doing well.
What genetic disease must be included in your initial differential diagnosis of this patient?
Answer Options:
This stem squarely describes infantile cholestasis: direct (conjugated) hyperbilirubinemia (direct fraction >20% of total), dark urine (renal excretion of conjugated bilirubin), and progressively pale/acholic stools (reduced bile pigment entering the gut), plus hepatosplenomegaly and elevated aminotransferases. Per NASPGHAN/ESPGHAN 2017 guidance, any infant with suspected cholestasis requires a structured evaluation and a differential that includes alpha-1 antitrypsin deficiency among the more common genetic/metabolic causes.
Alpha-1 antitrypsin (A1AT) deficiency (classically PiZZ) can present in early infancy with cholestasis, poor weight gain, hepatomegaly, and variable course—many improve, while a subset progress to chronic liver disease. The family history of a similar pattern in infancy with later improvement is compatible with the variable penetrance and course of A1AT-associated liver disease.
By contrast, Crigler-Najjar and Gilbert syndromes are disorders of bilirubin conjugation that produce unconjugated hyperbilirubinemia, and hereditary spherocytosis and G6PD deficiency cause hemolysis with predominantly unconjugated hyperbilirubinemia—none explain acholic stools/dark urine from conjugated bilirubin.
| Option | What It Tests / Implies | Why It’s Wrong Here |
|---|---|---|
| alpha-1 antitrypsin deficiency | Genetic/metabolic cause of neonatal cholestasis | Correct: fits conjugated hyperbilirubinemia, cholestasis symptoms, hepatosplenomegaly |
| Crigler-Najjar syndrome | Absent/low UGT activity → severe unconjugated bilirubin | Would cause indirect hyperbilirubinemia; acholic stools/dark urine not expected |
| hereditary spherocytosis | Hemolysis → increased bilirubin load | Predominantly unconjugated hyperbilirubinemia; stools not acholic from lack of bile flow |
| Gilbert disease | Mild reduced conjugation; intermittent unconjugated bilirubin | Typically older patients/teens; unconjugated pattern |
| G6PD deficiency | Oxidative hemolysis with jaundice | Hemolysis → unconjugated hyperbilirubinemia, not cholestasis |
Acholic stools + dark urine in an infant with direct bilirubin >20% of total = cholestasis, so think biliary atresia and genetic/metabolic liver disease (including A1AT deficiency)—not Gilbert/Crigler-Najjar or hemolysis.
The item forces you to commit to the bilirubin fraction: “direct >20% of total” plus dark urine and acholic stools is an exam-coded cholestasis pattern. The trap is reflexively picking familiar familial jaundice diagnoses (Gilbert/Crigler-Najjar) that are unconjugated disorders.
A 5-week-old has persistent jaundice, pale stools, and dark urine. Total bilirubin 8 mg/dL, direct bilirubin 5 mg/dL. What diagnosis must be urgently excluded?
A 2-month-old with cholestasis and hepatomegaly has a cousin with infant cholestasis who improved. Which test supports alpha-1 antitrypsin deficiency?
Which finding best indicates conjugated hyperbilirubinemia in an infant?
A 10-day-old has jaundice, anemia, reticulocytosis, and spherocytes on smear. Which bilirubin pattern is most likely?
A term newborn develops severe jaundice within 48 hours; total bilirubin 28 mg/dL with negligible direct fraction; no anemia. Which diagnosis fits best?
How would your differential and next diagnostic steps differ between (1) a 6-week-old with acholic stools and high direct bilirubin versus (2) a 2-day-old with very high indirect bilirubin and normal-colored stools?
Q1: What bilirubin threshold defines cholestasis in infants?
A: Boards commonly use direct bilirubin >1 mg/dL (if total ≤5) or >20% of total (if total >5); NASPGHAN/ESPGHAN (2017) emphasizes prompt evaluation once conjugated hyperbilirubinemia is identified.
Q2: Why are acholic stools so important on exams?
A: The ABP expects you to recognize acholic stools as a high-yield clue for impaired bile flow (cholestasis), which prioritizes biliary obstruction (e.g., biliary atresia) and metabolic/genetic liver disease.
Q3: Why don’t hemolysis conditions (G6PD, hereditary spherocytosis) fit this stem?
A: Hemolysis increases bilirubin production leading to unconjugated hyperbilirubinemia; it does not typically cause dark urine from conjugated bilirubin or acholic stools.
Q4: Where does alpha-1 antitrypsin deficiency fit in neonatal cholestasis?
A: It is a key genetic/metabolic etiology included in initial differentials per NASPGHAN/ESPGHAN (2017), classically presenting with infant cholestasis and variable long-term liver outcomes.
Find this and other Pediatric Medicine exam prep questions in Med-Challenger Pediatric Medicine Exam Review with CME
Try for free and save. Ace your exams and meet your CME/MOC requirements for just $35 a month!
No matter your program, no matter the size, Med-Challenger for Groups and Institutions can better prepare your program or group, fulfill industry requirements, and increase test scores.
For personal medical education that includes board's prep, MOC, and CME requirements, Med-Challenger has you covered in Family Medicine, Emergency Medicine, Internal Medicine, Pediatrics, Pediatric Emergency Medicine, OBGYN, Physician Assistants, and Nurse Practitioners.